We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Immunodiagnostic Systems Holdings Plc | LSE:IDH | London | Ordinary Share | GB00B01YZ052 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 378.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMIDH
RNS Number : 6461E
Immunodiagnostic Systems Hldgs PLC
05 July 2019
Immunodiagnostic Systems Holdings PLC
Director Dealing
5 July 2019
Immunodiagnostic Systems Holdings PLC ("IDS") a specialist producer of manual and automated diagnostic testing kits and instruments for the clinical and research markets, announces that on 3 July 2019 it granted share options ("Options") to Paul Martin, Group Finance Director, to acquire a total of 30,000 ordinary shares of 2p each in the capital of the Company under the Company's Co-Investment Executive Share Option Scheme.
The Options have been granted with an exercise price of GBP1.80 and subject to the satisfaction of performance conditions vest after a period of 3 years. The Options are exercisable over the period of 10 years from the date of grant.
The information set out below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014.
For further information:
Immunodiagnostic Systems Holdings Tel : +44 (0)191 plc 519 0660 Paul Martin, Group Finance Director Peel Hunt LLP Tel : +44 (0)207 418 8900 James Steel Oliver Jackson
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1. Details of the person discharging managerial responsibilities / person closely associated a. Name Paul Martin ------------------------------ ---------------------------------------------- 2. Reason for the notification ------------------------------------------------------------------------------ a. Position/status Group Finance Director ------------------------------ ---------------------------------------------- a. Initial notification Initial /Amendment ------------------------------ ---------------------------------------------- 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ------------------------------------------------------------------------------ a. Name Immunodiagnostic Systems Holdings plc ------------------------------ ---------------------------------------------- b. LEI 213800HZMYTD4NGF4L78 ------------------------------ ---------------------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted ------------------------------------------------------------------------------ a. Description Options over ordinary shares of 2p each of the in Immunodiagnostic Systems Holdings plc Financial instrument, Ordinary shares type GB00B01YZ052 of instrument Identification code ------------------------------ ---------------------------------------------- b. Nature of the Grant of options transaction ------------------------------ ---------------------------------------------- c. Price(s) and Option Volume(s) volume(s) price(s) GBP1.80 30,000 ---------- ------------------------------ ---------------------------------------------- d. Aggregated information N/A * Aggregated volume * Price ------------------------------ ---------------------------------------------- e. Date of the 2019-07-03 transaction ------------------------------ ---------------------------------------------- f. Place of the Outside trading venue - shares to be admitted transaction to AIM market of London Stock Exchange plc on exercise of options ------------------------------ ----------------------------------------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
DSHGCGDRGGGBGCU
(END) Dow Jones Newswires
July 05, 2019 05:02 ET (09:02 GMT)
1 Year Immunodiagnostic Systems Chart |
1 Month Immunodiagnostic Systems Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions